Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD). [electronic resource]
Producer: 19970415Description: 1094-9 p. digitalISSN:- 0008-543X
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Colorectal Neoplasms -- drug therapy
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Humans
- Infusions, Intravenous
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Recombinant Proteins
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.